MedTrace Logo

Pilot Study Using Transcranial Electrostimulation (TESA-HB) Therapy for the Treatment of Depressive Symptoms

NCT03471754 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2019-02-05

No results posted yet for this study

Summary

This pilot study uses TESA-HB therapy for treatment of depressive symptoms associated with mild and moderate depression episodes. Primary objectives of this pilot study are to demonstrate the safety of TESA-HB Therapy, and to investigate the efficacy of TESA-HB Therapy for depressive symptoms.

Conditions

  • Mild to Moderate Depression

Interventions

DEVICE

TESA-HB Transcranial Electronic Stimulation Device

Duration of treatment: 50 Minute Therapy sessions administered one time each day, for two 5-day cycles

Sponsors & Collaborators

  • Holy Redeemer Hospital

    collaborator OTHER

  • Annecto LLC

    lead OTHER

Principal Investigators

  • Beth DuPree, MD, MD · Holy Redeemer Hospital

  • Yakov Katsnelson, MD · Annecto LLC

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-26
Primary Completion
2019-01-31
Completion
2019-01-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03471754 on ClinicalTrials.gov